scispace - formally typeset
C

Carol Nieroda

Researcher at Ohio State University

Publications -  38
Citations -  1570

Carol Nieroda is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Radioimmunoguided surgery. The author has an hindex of 16, co-authored 26 publications receiving 1520 citations. Previous affiliations of Carol Nieroda include Uniformed Services University of the Health Sciences.

Papers
More filters
Journal ArticleDOI

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

TL;DR: This study demonstrates for the first time the ability to generate a human cytolytic T- cell response to specific epitopes of CEA in the context of major histocompatibility complex for T-cell-mediated lysis.
Journal ArticleDOI

In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen

TL;DR: These studies form a rational basis for the use of PSA peptides or recombinant vectors encoding PSA in the development of anticancer vaccine immunotherapy protocols for patients with prostate cancer.
Journal ArticleDOI

Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors

TL;DR: The authors have developed a hand-held gamma-detecting probe (GDP) for intraoperative use that improves the sensitivity of external radioimmunodetection and may influence the short-term morbidity and mortality of surgery for colorectal cancer.
Journal Article

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen

TL;DR: The serial phenotypic characterization of a CTL line directed against an immunodominant epitope (YLSGANLNL, designated CAP-1) of human carcinoembryonic antigen (CEA) is reported, showing it to be phenotypically stable.
Journal ArticleDOI

Intra-abdominal Recurrence of Colorectal Cancer Detected by Radioimmunoguided Surgery (RIGS System)

TL;DR: The RIGS system is more dependable in localizing clinically obscure metastases than other methods, and carcinoembryonic antigen testing remains the most accurate preoperative method to indicate suspected recurrences.